Qualitek Labs Ltd (544091)
Latest quarterly results (Q4 FY26)
In its latest reported quarter, Q4 FY26, Qualitek Labs' revenue was ₹70.0 Cr, and net profit ₹10.0 Cr; the operating margin was 25.7%.
| Q4 FY26 (₹ Cr) | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹70.0 | — | — |
| Operating profit | ₹18.0 | — | — |
| Net profit | ₹10.0 | — | — |
| EPS (₹) | 8.44 | — | — |
| Operating margin | 25.7% | — | — |
📢 Recent Corporate Announcements
Qualitek Labs Limited issued a corrigendum to its EGM notice for the meeting scheduled on October 16, 2026. The corrigendum amends the explanatory statement regarding proposed allottees and post-preferential issue shareholding patterns. Notably, ace investor Ashish Kacholia is slated to be allotted up to 1,73,200 equity shares, raising his holding from 4.35% (5,06,400 shares) to 5.65% (6,79,600 shares) post-issue. Additionally, promoter entity TIC Services Private Limited is slated to receive 5,20,000 warrants, bringing its post-conversion holding to 56.52% (70,98,375 shares).
- Ashish Kacholia proposed allotment of up to 1,73,200 equity shares, expanding holding from 4.35% to 5.65% post-issue
- TIC Services Private Limited proposed to receive up to 5,20,000 warrants, leading to a 56.52% post-warrant conversion stake
- EGM scheduled to be held on Friday, October 16, 2026 at 12:30 PM via Video Conferencing
- Multiple other individual and institutional investors proposed to receive small minority allocations of equity shares
Qualitek Labs Limited has issued an EGM notice for October 16, 2026, seeking shareholder approval for a preferential equity issue of up to 3,86,000 shares at ₹518.55 each. The proposed issue aggregates to approximately ₹20.02 crore, representing about 13.7% of the company's net worth of ₹146 crore. Notably, marquee investor Ashish Kacholia is slated to be allotted 1,73,200 shares (around 45% of the total issue). E-voting for eligible shareholders will take place between October 13 and October 15, 2026.
- Proposed preferential issue of up to 3,86,000 equity shares aggregating up to ₹20,01,60,300
- Issue price set at ₹518.55 per share (including a premium of ₹508.55 per share)
- Ace investor Ashish Kacholia proposed to receive 1,73,200 equity shares
- EGM scheduled for October 16, 2026, with cut-off date on October 09, 2026 and e-voting ending October 15, 2026
- Relevant date for ICDR pricing calculation determined as September 16, 2026
Qualitek Labs Limited announced that its Preferential Issue Committee approved the substitution of an allottee for its proposed preferential issue on September 23, 2026. Proposed non-promoter allottee Vibha Singhi, who was earmarked for 16,000 shares, has been replaced with Jagattaraini Tieup Private Limited for the same 16,000 shares. The overall list includes marquee investors such as Ashish Kacholia with 1,73,200 shares, along with 25 other entities. The preferential issue remains subject to shareholder and regulatory approvals, with all other previously approved terms unchanged.
- Replaced proposed allottee Vibha Singhi with Jagattaraini Tieup Private Limited for 16,000 equity shares
- Marquee non-promoter investor Ashish Rameshchandra Kacholia allocated 1,73,200 equity shares in the issue list
- Total list comprises 26 proposed allottees, including 25 non-promoters and 1 promoter (Kamal Grover with 1,200 shares)
- All other terms and conditions of the preferential issue remain unchanged mutatis mutandis
Qualitek Labs has approved a total fundraise of up to ₹46.98 crore via preferential allotment of equity shares and convertible warrants at an issue price of ₹518.55 each. The equity issuance comprises up to 3,86,000 shares aggregating ₹20.02 crore, with marquee investor Ashish Kacholia taking 1,73,200 shares. Additionally, 5,20,000 convertible warrants worth ₹26.96 crore will be issued to promoter entity TIC Services Private Limited. An Extra-Ordinary General Meeting (EGM) is scheduled for October 16, 2026, to seek shareholder approval.
- Approved issuance of up to 3,86,000 equity shares at ₹518.55 per share, raising ₹20.02 crore
- Approved issuance of up to 5,20,000 fully convertible warrants at ₹518.55 per warrant to promoter entity TIC Services Pvt Ltd, raising ₹26.96 crore
- Marquee investor Ashish Kacholia proposed to receive 1,73,200 equity shares (around 45% of the equity tranche)
- Total capital raise represents ~32% of existing net worth (₹146 crore)
- EGM convened for October 16, 2026, to secure shareholder approval
Qualitek Labs Limited has scheduled its 8th Annual General Meeting (AGM) for the financial year 2025–26 on Friday, September 25, 2026, at 11:30 AM IST in New Delhi. The cut-off date to determine shareholder eligibility for voting is Friday, September 18, 2026. Remote e-voting will commence on September 22, 2026 (09:00 AM IST) and conclude on September 24, 2026 (05:00 PM IST). This is a standard statutory compliance disclosure under SEBI LODR Regulations.
- 8th Annual General Meeting scheduled for Friday, September 25, 2026, at 11:30 AM IST
- Record/Cut-off date for voting eligibility set as Friday, September 18, 2026
- Remote e-voting window opens September 22, 2026 (09:00 AM IST) and closes September 24, 2026 (05:00 PM IST)
- Venue of the physical AGM is Avanta Business Centre, Statesman House, Connaught Place, New Delhi
Qualitek Labs held a board meeting on August 29, 2026, approving key resolutions ahead of its 8th Annual General Meeting scheduled for September 25, 2026. The board proposed increasing overall managerial remuneration limits from 28% to 35% of net profits under Section 198 of the Companies Act, with up to 30% for Executive Directors and up to 5% for Non-Executive Non-Independent Directors. Additionally, the board approved the re-appointment of tax auditor M/s J Madan & Associates for FY27, material related party transactions, and the re-appointment of MD Antaryami Nayak retiring by rotation. Remote e-voting for shareholders will run from September 22 to September 24, 2026, with a cut-off date of September 18, 2026.
- Board approved proposal to increase overall managerial remuneration limit from 28% to 35% of net profits
- Executive Director remuneration limit capped at up to 30% of net profits, with up to 5% for Non-Executive Non-Independent Directors
- 8th Annual General Meeting scheduled for Friday, September 25, 2026 at 11:30 AM IST
- Cut-off date for e-voting eligibility set for Friday, September 18, 2026
- Re-appointed M/s J Madan & Associates, CAs, as Tax Auditor for FY 2026–27
Qualitek Labs' Board has approved the draft notice for its 8th Annual General Meeting scheduled for 25th September, 2026 (cut-off date: 18th September, 2026). Key items proposed for shareholder approval include increasing the overall managerial remuneration cap from 28% to 35% of net profits (up to 30% for executive directors and 5% for non-executive non-independent directors). Additionally, the board recommended the re-appointment of MD & CEO Antaryami Nayak (retiring by rotation) and approved material related-party transactions for FY 2026-27.
- Board convened the 8th AGM on 25th September, 2026, with remote e-voting from 22nd to 24th September, 2026.
- Proposed increase in overall managerial remuneration limit from 28% to 35% of net profits under Section 198 of the Companies Act.
- Re-appointment of MD & CEO Antaryami Nayak, retiring by rotation, recommended for AGM approval.
- Approval of material Related Party Transactions for FY 2026-27 subject to member approval.
Qualitek Labs Ltd (Market Cap: ₹480 Cr) has informed the exchange of the resignation of Mr. Mohit Kumar, the Company Secretary and Compliance Officer, effective July 30, 2026. The resignation is attributed to personal pre-occupation and health issues, with the official confirming no other material reasons exist. As a Key Managerial Personnel (KMP), his departure requires the company to appoint a successor to maintain regulatory compliance. The company recently reported a TTM revenue of ₹113 Cr and a PAT of ₹13 Cr.
- Resignation of Mr. Mohit Kumar (ACS-38142) effective from close of business hours on July 30, 2026.
- The outgoing official served as both Company Secretary and Compliance Officer (Key Managerial Personnel).
- Reason for departure cited as pre-occupation and health issues, with no other material reasons disclosed.
- Company maintains a TTM revenue of ₹113 Cr and an operating profit margin of 24.9%.
Financial Performance
Revenue Growth by Segment
Standalone revenue grew 57% YoY to INR 45.8 Cr in FY25. Consolidated revenue reached INR 70.2 Cr, representing a 141% increase over the previous year's standalone base, primarily driven by the acquisition of ITC Labs which contributed INR 24.4 Cr post-acquisition. ITC Labs on a full-year standalone basis grew 25% to INR 40.6 Cr.
Geographic Revenue Split
Not explicitly disclosed by percentage, but operations are spread across key Indian hubs including Pune (Unit I & II), Noida, Bhubaneswar, Paradip, and Chennai, with a pan-India project footprint for the Ministry of Jal Shakti.
Profitability Margins
Consolidated Gross Margin (after direct expenses) stands at 85.5%. Consolidated Operating (EBITDA) margin is 24%, while the Net Profit (PAT) margin is 11%. Standalone PAT margin saw a decline from 15% to 11% due to initial setup expenses for the mineral business and the Noida laboratory.
EBITDA Margin
Consolidated EBITDA margin is 24% (INR 16.8 Cr). Standalone EBITDA margin is 26% (INR 11.9 Cr), which is a 2% decrease from the 28% margin in FY24, reflecting higher operational costs during expansion phases.
Capital Expenditure
Significant investment was directed toward the acquisition of Interstellar Testing Centre Pvt. Ltd (ITC Labs) on September 11, 2024, and the establishment of new lab units in Noida and Pune (Unit II). Specific INR Cr value for total CAPEX is not disclosed.
Credit Rating & Borrowing
The Company reported a Debt-Equity Ratio of 0.5 in FY25. Finance costs for the consolidated entity were INR 2.1 Cr, representing approximately 3% of total revenue.
Operational Drivers
Raw Materials
Laboratory chemicals, reagents, and testing consumables, which collectively represent 14.5% of consolidated revenue (INR 10.2 Cr).
Import Sources
Sourced domestically and internationally to meet NABL and ISO standards, though specific countries are not listed.
Capacity Expansion
Expanded footprint with the addition of Pune Unit II in 2023 and a new Noida unit in 2021/2024. The acquisition of ITC Labs added facilities in Panchkula and Chennai. Current employee strength is 550 as of March 2025.
Raw Material Costs
Cost of Material Consumed and Other Direct Expenses totaled INR 10.2 Cr (14.5% of revenue). Standalone material costs grew 34% YoY to INR 7.5 Cr, trailing the 57% revenue growth, indicating improved procurement efficiency.
Manufacturing Efficiency
Growth in FY25 was attributed to improved lab utilization and the successful execution of high-volume government projects like the Ministry of Jal Shakti (1.47 lakh samples).
Logistics & Distribution
Not disclosed as a separate percentage, but critical for sample intake and traceability via the cloud-based LIMS.
Strategic Growth
Expected Growth Rate
82%
Growth Strategy
Growth is targeted through the integration of ITC Labs, expansion into the mineral testing business, and scaling operations in Noida and Pune. The company is leveraging strategic tie-ups with international bodies like RID China, STC-HK, and QAV Malaysia to capture export-oriented testing demand.
Products & Services
Analytical testing, inspection, and certification services for automotive, defense, environment, food, pharmaceuticals, and minerals sectors.
Brand Portfolio
Qualitek Labs, ITC Labs (Interstellar Testing Centre).
New Products/Services
Launched a new mineral business segment in FY25; initial setup costs for this and the Noida lab impacted short-term PAT margins by 4%.
Market Expansion
Targeting untapped geographical markets and new customer segments in EVs, pharma, and food safety through NABL-accredited facilities.
Market Share & Ranking
Not disclosed, but the company reported market share gains in FY25 due to expansion and improved lab utilization.
Strategic Alliances
Collaborations with RID China (Food & Cosmetics), STC-HK (Automotive/Electronics), QAV Malaysia (Automotive), and GLAB Germany (Pharma/Auto).
External Factors
Industry Trends
The TIC industry is witnessing rapid expansion (82% revenue CAGR for the company) driven by rising quality consciousness and stricter regulatory compliance in India.
Competitive Landscape
Operates in a fragmented market with competition from both local labs and international TIC majors, though its MSME status and local accreditations provide a niche advantage.
Competitive Moat
Moat is built on NABL/ISO accreditations, a cloud-based LIMS for traceability, and a pan-India lab network. These are sustainable due to high regulatory barriers to entry and the technical expertise required for certification.
Macro Economic Sensitivity
Highly sensitive to government initiatives like 'Make in India' and increased export compliance requirements which drive the need for third-party testing.
Consumer Behavior
Increasing consumer demand for food safety and product quality is forcing manufacturers to increase testing frequency.
Geopolitical Risks
Trade barriers or changes in international quality standards (ISO/IEC) could impact the validity of current certifications and require new investments.
Regulatory & Governance
Industry Regulations
Operations are governed by NABL (ISO/IEC 17025), EIC, and sector-specific norms for Automotive, Pharma, and Food safety. Compliance is monitored via internal audits and the cloud-based LIMS.
Environmental Compliance
The company is ISO 14001 certified and focuses on environmental sustainability as part of its CSR and operational mandate.
Taxation Policy Impact
Effective tax rate is approximately 26% (INR 2.7 Cr tax on INR 10.4 Cr PBT).
Legal Contingencies
No significant or material orders were passed by regulators, courts, or tribunals during the year that would impact the company's status as a going concern.
Risk Analysis
Key Uncertainties
Integration risks from the ITC Labs acquisition and the ability to maintain high lab utilization at new facilities in Noida and Pune. Potential impact of 5-10% on margins if utilization lags.
Geographic Concentration Risk
Concentrated in India, with major revenue hubs in Maharashtra (Pune), Delhi/NCR (Noida), and Odisha (Bhubaneswar/Paradip).
Third Party Dependencies
Dependent on NABL for accreditation renewals and specialized equipment vendors for lab maintenance.
Technology Obsolescence Risk
Mitigated by regular infrastructure upgrades and the implementation of a cloud-based Laboratory Information Management System (LIMS).
Credit & Counterparty Risk
Current ratio declined from 1.70 to 0.96 in FY25, indicating a tighter liquidity position and higher reliance on short-term borrowings.
